Health technology assessment (HTA) framework plays an important role in market access for medical devices in Norway.
Since 2013, all innovative medical technologies entering the Norwegian market must undergo evaluation and obtain a coverage decision within the national “New methods” (Nye Metoder) framework. The framework applies to all innovative medical technologies and procedures, and specific brands of devices can be considered. The recommendations provided by this framework determine the funding (coverage) of the assessed technologies by Regional Health Authorities and influence the inclusion of the new technologies in the national clinical guidelines.
This White Paper provides an opportunity to learn about the evidence requirements related to the 'New Methods' framework from the 5 recent med tech assessments in Norway. The review is followed by recommendations about evidence generation and will be useful for medical device manufacturers seeking market access in Norway, as well as HTA professionals and policymakers interested in the Norwegian evaluation framework.
Request White Paper
Request this analytical White Paper to gain strategic insights into the evidence requirements for medical devices under the “New Methods” framework in Norway